Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dydrogesterone versus Cyclogest for threatened abortion
IRCT20120104008611N8Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in threatened abortion comparing Cyclogest with dydrogesterone (2 arms). Primary endpoints: Preterm labor, Preeclampsia and 3 more. Started May 2017; status: completed.
02
Drugs
progesteronedydrogesterone
03
Conditions
threatened abortion
Beyond the preview
Go deeper on IRCT20120104008611N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120104008611N8.